HBK Sorce Advisory’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $382K | Buy |
1,444
+3
| +0.2% | +$830 | 0.01% | 447 |
|
|
2026
Q1 | $405K | Buy |
1,441
+30
| +2% | +$8.91K | 0.01% | 419 |
|
|
2025
Q4 | $426K | Buy |
1,411
+170
| +14% | +$46.2K | 0.01% | 395 |
|
|
2025
Q3 | $333K | Buy |
1,241
+51
| +4% | +$13.9K | 0.01% | 448 |
|
|
2025
Q2 | $328K | Buy |
1,190
+333
| +39% | +$90.6K | 0.01% | 438 |
|
|
2025
Q1 | $227K | Buy |
+857
| New | +$211K | 0.01% | 511 |
|
|
2022
Q1 | – | Sell |
-1,358
| Closed | -$310K | – | 565 |
|
|
2021
Q4 | $310K | Buy |
1,358
+4
| +0.3% | +$880 | 0.02% | 440 |
|
|
2021
Q3 | $262K | Sell |
1,354
-295
| -18% | -$59.8K | 0.01% | 474 |
|
|
2021
Q2 | $351K | Sell |
1,649
-3
| -0.2% | -$633 | 0.02% | 410 |
|
|
2021
Q1 | $337K | Buy |
1,652
+6
| +0.4% | +$1.18K | 0.02% | 380 |
|
|
2020
Q4 | $300K | Sell |
1,646
-354
| -18% | -$60.2K | 0.02% | 374 |
|
|
2020
Q3 | $335K | Buy |
2,000
+519
| +35% | +$87.4K | 0.02% | 332 |
|
|
2020
Q2 | $241K | Buy |
1,481
+2
| +0.1% | +$358 | 0.02% | 372 |
|
|
2020
Q1 | $256K | Sell |
1,479
-1,268
| -46% | -$252K | 0.02% | 319 |
|
|
2019
Q4 | $552K | Sell |
2,747
-56
| -2% | -$11.5K | 0.05% | 252 |
|
|
2019
Q3 | $592K | Sell |
2,803
-56
| -2% | -$11.7K | 0.06% | 229 |
|
|
2019
Q2 | $555K | Sell |
2,859
-57
| -2% | -$10.5K | 0.05% | 231 |
|
|
2019
Q1 | $480K | Buy |
2,916
+163
| +6% | +$28.8K | 0.05% | 251 |
|
|
2018
Q4 | $518K | Buy |
2,753
+76
| +3% | +$14K | 0.06% | 216 |
|
|
2018
Q3 | $456K | Sell |
2,677
-104
| -4% | -$17.5K | 0.05% | 233 |
|
|
2018
Q2 | $456K | Sell |
2,781
-110
| -4% | -$18K | 0.05% | 238 |
|
|
2018
Q1 | $468K | Buy |
2,891
+242
| +9% | +$38.5K | 0.06% | 227 |
|
|
2017
Q4 | $387K | Sell |
2,649
-45
| -2% | -$6.41K | 0.05% | 267 |
|
|
2017
Q3 | $366K | Buy |
2,694
+378
| +16% | +$47.8K | 0.06% | 217 |
|
|
2017
Q2 | $290K | Buy |
2,316
+32
| +1% | +$3.83K | 0.05% | 242 |
|
|
2017
Q1 | $271K | Sell |
2,284
-8
| -0.3% | -$962 | 0.05% | 258 |
|
|
2016
Q4 | $264K | Sell |
2,292
-48
| -2% | -$5.34K | 0.05% | 251 |
|
|
2016
Q3 | $245K | Sell |
2,340
-194
| -8% | -$20.3K | 0.05% | 246 |
|
|
2016
Q2 | $247K | Buy |
+2,534
| New | +$239K | 0.05% | 228 |
|
Other funds holding CME
HBK Sorce Advisory's CME Position: Q2 2026 in Review
HBK Sorce Advisory increased its CME Group (CME) stake by 0.21% in Q2 2026, buying an estimated $830 and bringing the position to 1,444 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #447.
HBK Sorce Advisory first reported a position in CME in Q2 2016 and has held it in 29 quarters since. The position peaked at $592K in Q3 2019. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- HBK Sorce Advisory held 1,444 shares of CME Group worth $382K as of Q2 2026.
- HBK Sorce Advisory bought 3 CME Group shares in Q2 2026, an estimated $830.
- CME Group made up 0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #447 holding.
- HBK Sorce Advisory first reported a position in CME Group in Q2 2016 and has held it in 29 quarters since.
- HBK Sorce Advisory's CME Group position peaked at $592K in Q3 2019.
- 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.